Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-04-11 Purchase |
2024-04-15 08:53 am |
Acrivon Therapeutics Inc. | ACRV | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD EDELMAN JOSEPH 10% Owner |
2,353,000 | $8.5 | $20,000,500 | 5,360,858 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-08-14 Tax Withholding |
2024-08-16 4:47 pm |
N/A N/A |
Acrivon Therapeutics Inc. | ACRV | Blume-Jensen Peter President and CEO |
59,765 | $7.02 | 2,819,375 (Direct) |
View |
| 2024-07-17 Tax Withholding |
2024-07-19 4:20 pm |
N/A N/A |
Acrivon Therapeutics Inc. | ACRV | Miller Mary Chief Legal Officer |
558 | $7.69 | 39,151 (Direct) |
View |
| 2024-06-20 Option Award |
2024-06-24 5:36 pm |
N/A 2034-06-19 |
Acrivon Therapeutics Inc. | ACRV | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
20,275 | $0 | 20,275 (Indirect) |
View |
| 2024-06-20 Option Award |
2024-06-24 5:28 pm |
N/A 2034-06-19 |
Acrivon Therapeutics Inc. | ACRV | TOMSICEK MICHAEL JOHN Director |
20,275 | $0 | 20,275 (Direct) |
View |
| 2024-06-20 Option Award |
2024-06-24 5:27 pm |
N/A 2034-06-19 |
Acrivon Therapeutics Inc. | ACRV | Shacham Sharon Director |
20,275 | $0 | 20,275 (Direct) |
View |
| 2024-06-20 Option Award |
2024-06-24 5:27 pm |
N/A 2034-06-19 |
Acrivon Therapeutics Inc. | ACRV | DiRocco Derek Director |
20,275 | $0 | 20,275 (Direct) |
View |
| 2024-06-20 Option Award |
2024-06-24 5:26 pm |
N/A 2034-06-19 |
Acrivon Therapeutics Inc. | ACRV | BAUM CHARLES M Director |
20,275 | $0 | 20,275 (Direct) |
View |
| 2024-05-17 Exercise |
2024-05-21 4:04 pm |
N/A 2031-01-13 |
Acrivon Therapeutics Inc. | ACRV | Devroe Eric Chief Operating Officer |
10,000 | $0 | 155,712 (Direct) |
View |
| 2024-05-17 Exercise |
2024-05-21 4:04 pm |
N/A N/A |
Acrivon Therapeutics Inc. | ACRV | Devroe Eric Chief Operating Officer |
10,000 | $1.04 | 155,712 (Direct) |
View |
| 2024-05-14 Tax Withholding |
2024-05-16 7:05 pm |
N/A N/A |
Acrivon Therapeutics Inc. | ACRV | Peterson Katharine Chief Accounting Officer |
99 | $8.36 | 4,733 (Direct) |
View |
| 2024-05-14 Tax Withholding |
2024-05-16 7:03 pm |
N/A N/A |
Acrivon Therapeutics Inc. | ACRV | Miller Mary Chief Legal Officer |
184 | $8.36 | 39,709 (Direct) |
View |
| 2024-05-14 Tax Withholding |
2024-05-16 7:02 pm |
N/A N/A |
Acrivon Therapeutics Inc. | ACRV | Masson Kristina EVP - Business Operations |
490 | $8.36 | 2,879,630 (Direct) |
View |
| 2024-05-14 Tax Withholding |
2024-05-16 7:00 pm |
N/A N/A |
Acrivon Therapeutics Inc. | ACRV | Holm-Jorgensen Rasmus Chief Financial Officer |
368 | $8.36 | 27,258 (Direct) |
View |
| 2024-05-14 Tax Withholding |
2024-05-16 6:58 pm |
N/A N/A |
Acrivon Therapeutics Inc. | ACRV | Gamelin Erick Chief Development Officer |
402 | $8.36 | 17,765 (Direct) |
View |
| 2024-05-14 Tax Withholding |
2024-05-16 6:56 pm |
N/A N/A |
Acrivon Therapeutics Inc. | ACRV | Devroe Eric Chief Operating Officer |
613 | $8.36 | 59,097 (Direct) |
View |
| 2024-05-14 Tax Withholding |
2024-05-16 6:54 pm |
N/A N/A |
Acrivon Therapeutics Inc. | ACRV | Blume-Jensen Peter President and CEO |
54,918 | $8.36 | 2,879,630 (Direct) |
View |
Ownership |
2024-05-16 6:52 pm |
N/A N/A |
Acrivon Therapeutics Inc. | ACRV | Peterson Katharine Chief Accounting Officer |
0 | $0 | 95,328 (Direct) |
View |
| 2024-04-17 Tax Withholding |
2024-04-19 4:10 pm |
N/A N/A |
Acrivon Therapeutics Inc. | ACRV | Miller Mary Chief Legal Officer |
558 | $10.34 | 39,893 (Direct) |
View |
| 2024-04-11 Option Award |
2024-04-15 4:15 pm |
N/A N/A |
Acrivon Therapeutics Inc. | ACRV | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
3,530,000 | $8.5 | 8,340,508 (Indirect) |
View |
| 2024-03-04 Option Award |
2024-03-06 4:32 pm |
N/A 2034-03-03 |
Acrivon Therapeutics Inc. | ACRV | Palani Santhosh Director |
32,500 | $0 | 32,500 (Direct) |
View |
| 2024-02-14 Tax Withholding |
2024-02-16 5:14 pm |
N/A N/A |
Acrivon Therapeutics Inc. | ACRV | Miller Mary Chief Legal Officer |
217 | $3.4 | 40,451 (Direct) |
View |
| 2024-02-14 Tax Withholding |
2024-02-16 5:13 pm |
N/A N/A |
Acrivon Therapeutics Inc. | ACRV | Masson Kristina EVP - Business Operations |
579 | $3.4 | 2,935,038 (Direct) |
View |
| 2024-02-14 Tax Withholding |
2024-02-16 5:12 pm |
N/A N/A |
Acrivon Therapeutics Inc. | ACRV | Holm-Jorgensen Rasmus Chief Financial Officer |
434 | $3.4 | 27,626 (Direct) |
View |
| 2024-02-14 Tax Withholding |
2024-02-16 5:10 pm |
N/A N/A |
Acrivon Therapeutics Inc. | ACRV | Gamelin Erick Chief Development Officer |
468 | $3.4 | 18,167 (Direct) |
View |
| 2024-02-14 Tax Withholding |
2024-02-16 5:08 pm |
N/A N/A |
Acrivon Therapeutics Inc. | ACRV | Devroe Eric Chief Operating Officer |
723 | $3.4 | 59,710 (Direct) |
View |
| 2024-02-14 Tax Withholding |
2024-02-16 5:06 pm |
N/A N/A |
Acrivon Therapeutics Inc. | ACRV | Blume-Jensen Peter President and CEO |
41,861 | $3.4 | 2,935,038 (Direct) |
View |
| 2024-02-08 Option Award |
2024-02-09 4:37 pm |
N/A 2034-02-07 |
Acrivon Therapeutics Inc. | ACRV | Magovcevic-Liebisch Ivana Director |
32,500 | $0 | 32,500 (Direct) |
View |
| 2024-01-17 Tax Withholding |
2024-01-19 4:24 pm |
N/A N/A |
Acrivon Therapeutics Inc. | ACRV | Miller Mary Chief Legal Officer |
652 | $4.35 | 40,668 (Direct) |
View |
| 2024-01-11 Option Award |
2024-01-16 4:45 pm |
N/A 2034-01-10 |
Acrivon Therapeutics Inc. | ACRV | Cuillerot Jean-Marie Chief Medical Officer |
99,300 | $0 | 99,300 (Direct) |
View |
| 2023-11-14 Tax Withholding |
2023-11-16 7:43 pm |
N/A N/A |
Acrivon Therapeutics Inc. | ACRV | Miller Mary Chief Legal Officer |
735 | $5.08 | 41,320 (Direct) |
View |
| 2023-11-14 Tax Withholding |
2023-11-16 7:42 pm |
N/A N/A |
Acrivon Therapeutics Inc. | ACRV | Masson Kristina EVP - Business Operations |
1,900 | $5.08 | 2,977,478 (Direct) |
View |
| 2023-11-14 Tax Withholding |
2023-11-16 7:42 pm |
N/A N/A |
Acrivon Therapeutics Inc. | ACRV | Holm-Jorgensen Rasmus Chief Financial Officer |
1,470 | $5.08 | 28,060 (Direct) |
View |
| 2023-11-14 Tax Withholding |
2023-11-16 7:41 pm |
N/A N/A |
Acrivon Therapeutics Inc. | ACRV | Gamelin Erick Chief Medical Officer |
1,395 | $5.08 | 18,635 (Direct) |
View |
| 2023-11-14 Tax Withholding |
2023-11-16 7:41 pm |
N/A N/A |
Acrivon Therapeutics Inc. | ACRV | Devroe Eric Chief Operating Officer |
2,450 | $5.08 | 60,433 (Direct) |
View |
| 2023-11-14 Tax Withholding |
2023-11-16 7:41 pm |
N/A N/A |
Acrivon Therapeutics Inc. | ACRV | Blume-Jensen Peter President and CEO |
239,023 | $5.08 | 2,977,478 (Direct) |
View |
| 2023-10-17 Tax Withholding |
2023-10-19 7:45 pm |
N/A N/A |
Acrivon Therapeutics Inc. | ACRV | Miller Mary Chief Legal Officer |
2,232 | $5.48 | 42,055 (Direct) |
View |
| 2023-09-26 Option Award |
2023-09-28 7:17 pm |
N/A 2033-09-25 |
Acrivon Therapeutics Inc. | ACRV | Miller Mary Chief Legal Officer |
15,434 | $0 | 55,863 (Direct) |
View |